Abstract:Objective To investigate the etiopathogenesis of Parkinson' s disease (PD) and the mechanism of action of the gastrodin in order to prevent and cure PD. Methods Male Wistar rats were left-striatum injected with 6-OHDA (20 μg) to establish PD model. To observe the effect of gastrodin on the expression of Tyrosine hydroxylase positive (TH +) and Caspase-3 positive (Caspase-3 +) neurons in substantia nigra pars compacta (SNpc) and ventral tegmental area (VTA) by immunohistochemistry technique. Results There were statistically significant differences in the levels of TH + neurons in SNpc and VTA in rats of PD disease between groups (F = 13.29,5.04, P ＜0.01). To compared with normal group[(32.13 ±4.84), (30.23 ± 3.21)], the levels of TH + neurons in SNpc and VTA in rats in model group (18.89 ± 3.73,24.20 ± 6.35) were significantly decreased (P ＜ 0.01),the loss of TH + neurons declined after treatment with gastrodin or madopar, the levels of TH + neurons in SNpc and VTA in rats in small dose group[(26. 24 ± 3.06), (26.31 ± 6. 1)], in middle dose group[(22.4 ± 3.81),(26.91 ±6.28)], in large dose group[(20.95 ±4.71),(27.3 ±7.1)]and in madopar group[(27.89 ±4. 56), (25.97 ±5.14)]were obviously increased, the levels of TH + neurons in SNpc in rats in small dose group and in madopar group were significantly increased (P ＜ 0.05). There were statistically significant differences in the levels of Caspase-3 + neurons in SNpc and VTA of rats of PD disease between groups (F = 6. 09,5. 53, P ＜ 0. 01).To compared with normal group[(9.83 ± 3.03), (7.04 ± 1.76)], the levels of Caspase-3 + neurons in SNpc and VTA in rats in model group[(14.53 ± 2.33), (12.84 ± 2.58)]were significantly increased (P ＜ 0.01), the levels of Caspase-3 .+ neurons in SNpc and VTA in rats in small dose group[(10.68 ± 1.83), (7.72 ± 1.92)], in middle dose group[(11.29 ± 2.8), (10.38 ± 3.79)], in large dose group[(11.89 ± 2.97), (11.37 ± 1.86)]and in madopar group[(9.99 ± 3.3), (10.69 ± 3.11)]were obviously decreased, the levels of Caspase-3 + neurons in SNpc in madopar group and in VTA in small dose group were significantly decreased (P ＜ 0.05). The trend of change of TH + neurons is opposite to that of Caspase-3 + neurons in gastrodin or madopar treatment groups. Conclusion Gastrodin may suppress the loss and apoptosis in SNpc by adjusting Caspase-3. The effect of small dose group is better,suggesting gastrodin can have different neuroprotection on dopamine neuron.

An Activated Sympathetic Nervous System Affects White Adipocyte Differentiation and Lipolysis in a Rat Model of Parkinson's Disease

Increased Energy Expenditure and Activated Β3‐ar‐camp‐pka Signaling Pathway in the Interscapular Brown Adipose Tissue of 6‐ohda‐induced Parkinson's Disease Model Rats

MPTP-Induced Impairment of Cardiovascular Function

Resistance to high-fat diet-induced weight gain in transgenic mice overexpressing human wild-type α-synuclein: A model for metabolic dysfunction in Parkinson's disease

Reducing the lipase LIPE in mutant α-synuclein mice improves Parkinson-like deficits and reveals sex differences in fatty acid metabolism

Schwann cell-specific Pten inactivation reveals essential role of the sympathetic nervous system activity in adipose tissue development

Dopamine receptor 2 downregulation and brain-derived neurotrophic factor upregulation in the paraventricular nucleus are correlated with brown adipose tissue thermogenesis in rats with bilateral substantia nigra lesions

Lipoic Acid Protects Dopaminergic Neurons in LPS-induced Parkinson's Disease Model.

Loss of Brain Norepinephrine Elicits Neuroinflammation-Mediated Oxidative Injury and Selective Caudo-Rostral Neurodegeneration

Metabolic energy decline coupled dysregulation of catecholamine metabolism in physiologically highly active neurons: implications for selective neuronal death in Parkinson's disease

Reduced Lipolysis Response to Adipose Afferent Reflex Involved in Impaired Activation of Adrenoceptor-Camp-pka-hormone Sensitive Lipase Pathway in Obesity.

The Effect of Gastrodin on Expression of Apoptosis and Tyrosine Hydroxylase Neurons in Substantia Nigra Pars Compacta in Rats of Parkinson' S Disease

Loss of substantia nigra neurons in Parkinson disease rats

Unravelling the mechanisms of underweight in Parkinson’s disease by investigating into the role of gut microbiome

Metabolic demand regulates selective cell death in Parkinson’s Disease

Obesity differentially effects the somatosensory cortex and striatum of TgF344-AD rats

Downregulation of Lncrna BACE1-AS Improves Dopamine-Dependent Oxidative Stress in Rats with Parkinson’s Disease by Upregulating Microrna-34B-5p and Downregulating BACE1

A Breakdown in Microglial Metabolic Reprogramming Causes Internalization Dysfunction of Α-Synuclein in a Mouse Model of Parkinson’s Disease

Parkin regulates neuronal lipid homeostasis through SREBP2-lipoprotein lipase pathway—implications for Parkinson's disease

Autophagic Impairment Contributes To Systemic Inflammation-Induced Dopaminergic Neuron Loss In The Midbrain